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Abstract.  We have isolated a human cDNA which 
corresponds to a developmentally regulated sarco- 
meric myosin heavy chain. RNA hybridization and 
DNA sequence analysis indicate that this cDNA, 
called SMHCP, encodes a perinatal myosin heavy 
chain isoform. The nucleotide and deduced amino acid 
sequences of the 3.4-kb  cDNA insert show strong ho- 
mology with other sarcomeric myosin heavy chains. 
The strongest homology is to a previously described 
970-bp cDNA encoding a rat perinatal isoform (Peri- 
asamy, M., D.  E  Wieczorek, and B. Nadal-Ginard. 
1984.  J.  Biol.  Chem.  259:13573-13578).  The homol- 
ogy between the analogous human and rat perinatal 
myosin heavy chain cDNAs is maintained through the 
highly isoform-specific final 20 carboxyl-terminal 
amino acids, as well as the 3' untranslated region. 
Ribonuclease protection studies show that the mRNA 
encoding this isoform is expressed at high levels in 
21-wk fetal skeletal  tissue and not in fetal cardiac mus- 
cle. In contrast to the rat perinatal isoform, which was 
not found to be expressed in adult hind-leg tissue, the 
gene encoding SMHCP continues to be expressed in 
adult human skeletal  tissue, but at lower levels relative 
to fetal skeletal  tissue. 
T  rIE myosin molecule, through its interaction with ac- 
tin, generates  movement in processes  as diverse  as 
cytokinesis  and muscle  contraction.  The hexameric 
myosin molecule consists of a pair of myosin heavy chains 
(MHC) ~ and two pairs  of myosin light chains.  The heavy 
chains contain the site of ATP hydrolysis and the sequences 
that  comprise  the  thick  filament.  Vertebrate sarcomeric 
MHCs  are  encoded  by  multigene  families  encompassing 
10-15 genes (11, 35) each encoding a distinct protein, or iso- 
zyme. Members of  this gene family show both tissue-specific 
and developmentally regulated expression (10, 19, 34). Dur- 
ing development, fetal, neonatal, and adult MHC isozymes 
are expressed  in a sequential program  (1,  3,  14,  32,  33). 
However, the functional  significance of each of these iso- 
zymes,  and the mechanisms by which their expression is 
regulated, have yet to be clarified. It may be that changes in 
the physiological properties of the developing muscle neces- 
sitate switches in MHC isozyme expression to accommodate 
new demands. 
cDNA and genomic clones corresponding to several sarco- 
meric MHC isoforms have been isolated and found to show 
strong  homology to each  other.  These  include  sequences 
from chicken (18), rat (15, 20, 27, 35), rabbit (4, 8), mouse 
(31), and human (23, 24) striated muscle. When sequences 
This  sequence has been registered with the EMBL/GenBank,  accession 
number Y00821. 
1. Abbreviations used in thispaper: MHC, myosin heavy chain; UTR, un- 
translated region. 
of analogous MHC isoforms from different species are com- 
pared,  they are  even more homologous than  intraspecies 
comparisons, suggesting functional constraints on the diver- 
gence of  isoform sequences. The 3' untranslated region (UTR) 
sequences are also maintained across species when analo- 
gous isoforms are compared, and appear to be quite isoform 
specific (19, 20). 
The patterns of MHC isoform expression in muscle fiber 
types during  vertebrate  skeletal muscle development have 
been investigated using a variety of cyto- and immunochemi- 
cal techniques.  Using anti-myosin monoclonal antibodies, 
Silberstein and Blau (25) have shown that in human skeletal 
muscle at 17 wk of gestation, two populations of myotubes 
begin to emerge; all fibers react with an anti-fetal MHC anti- 
body, while a small subpopulation also reacts with an anti- 
slow MHC antibody. By 30 wk of gestation, a population of 
fibers which is stained by anti-fetal and anti-fast antibodies 
has emerged, and some slow fibers no longer express any fe- 
tal MHC; only a small percentage of the total fibers do not 
yet express either fast or slow MHC. By birth, few fibers still 
express a fetal isoform. By one year, no fibers appear to ex- 
press fetal MHC, and the distribution of fast and slow fibers 
changes very little as compared to adult tissue (30). 
To study the progression of MHC gene expression during 
human muscle development, we have isolated eDNA clones 
corresponding to four human sarcomeric myosin gene prod- 
ucts.  These  include  adult-fast  and  slow-skeletal  muscle 
MHCs (22,  23) along with a human  fetal skeletal eDNA 
clone  (Karsch-Mizrachi,  I.,  M.  Travis, H.  Blau,  and L. 
Leinwand, manuscript submitted for publication). In this pa- 
© The Rockefeller University Press, 0021-9525/89/05/1791/7 $2.00 
The Journal of Cell Biology, Volume 108, May 1989 1791-1797  1791 Q  K  T  K  0  £  L  A  K  5  E  A  K  R  K  E  L  E  E  K 
cAGAAAACCAAAGATGAACTCGCCAAGTCAGAGGCAAAAC  GGAAGGAGCTAGAGGAAAAA 
10  20  30  40  50  60 
H  V  T  L  L  K  C  K  H  D  L  Q  L  O  v  O  S  £  A  D 
AT  GGTCACTC  TCTTAAAAGAGAAAAATGAC  CTGCAACTCC  AGGTTCAATC  TGAAGCAGAT 
70  90  90  100  110  120 
S  L  ^  O  A  E  £  R  C  [  Q  L  I  K  N  K  Z  O  L  E 
AGCTTGGCTGATGC&GAGGAAAGGTGTG  AGCAACTGATTAAAAACAAAATCCAACTTG  AG 
130  140  150  160  170  100 
A  K  ~  K  r  v  T  £  R  A  [  E  £  £  £  I  N  A  £  L 
GC  CAAAATCAAAGAGGTGACTGAAAGAGCTGAGGAGGAGGAAGAGATC  AATGCT  GAGCTG 
190  200  210  220  230  240 
T  A  K  K  R  K  L  £  D  £  C  S  E  L  ~  ~  D  ~  D  D 
ACAGCCAAGAAGAGAJ~AACTGGAGGATGAATGTTCAGAACTCAAGAAAGACATTGATGAC 
250  260  270  280  290  300 
L  E  L  T  L  A  K  V  £  K  O  K  R  A  T  E  H  K  V  K 
CTTGAGCTGACACTGGCC  AAGGTTGAGAAGCAGAAACATGCCACGGAGAACAAGGTGAAA 
310  320  330  340  350  360 
N  L  T  £  £  M  A  G  L  D  £  T  Z  A  ~  L  S  K  £  K 
AATCTTACAGAAGAGATGGCAGGCCTGGATGAAACCA  T  TGCAAAACTGTC  C-qAGGAGAAG 
370  380  390  400  410  420 
K  A  L  O  £  T  R  O  Q  T  L  D  0  L  O  ^  £  £  D  K 
AAGGCTCT  C  CAAGAGACCCACCAGCAGACCCT  GGATG&CCTGCAGGCAGAGGAGGACAAA 
430  440  450  460  470  460 
V  N  I  L  T  K  A  K  T  K  L  £  O  Q  V  D  D  L  E  G 
GTCAACATCCTGACCAAAGCTAAAACCAAGCTAGAACAGCAAGTGGAT  GATCTTGAAGGG 
490  500  510  520  530  540 
S  L  £  O  E  K  K  L  R  M  0  L  E  R  &  K  R  K  r.  £ 
TCTCTGGAACAAGAAAAGAAGCTTCGAATGGATCTAGAAAGAGCAAAGCGGAAACTGGAG 
550  560  570  580  590  600 
G  0  L  K  L  A  0  E  ~  T  M  0  H  £  H  D  K  O  0  L 
GGTGACCTCAAATTGGCCCAAGAATCCACAAIaC,  GATATGGAAAATGACAAACAGCAACTT 
610  620  630  640  650  &60 
0  E  K  L  E  K  K  E  F  E  I  S  N  L  Z  S  K  I  £  D 
GATGAAAAGC  TT  GAAAAG  AAAGAATTT  GAAATCAGCAATT  TGAT  AAGC  AAAATTGAAGAT 
670  680  690  700  710  720 
E  (]  A  V  E  I  0  L  O  K  K  1  K  E  L  Q  A  R  I  £ 
GAGCAAGCTGTAGAAATTCAACTACAGAAGAAGATCAAAGAGTTGCAGGCCCGCATTGAG 
730  740  ?50  760  770  780 
K  L  G  E  E  I  E  A  E  R  A  $  R  &  K  A  E  K  0  R 
GAGCTGGGGGAAGAAATC  GAGGCAGAGAGGGCGTCCCGAGCCAAAGCGGAGA~GC  GC 
";80  800  810  820  830  840 
S  D  L  S  R  E  L  E  E  I  S  E  R  L  £  E  &  G  G  A 
TCTGACCTCTCCCGGGAACTGGAGGAGATCAGCGAGAGGCTGGAAGAAGCCGGTGGGGCA 
050  880  870  880-  890  900 
T  S  A  O  V  £  L  N  K  K  R  E  A  £  F  Q  iT  L  R  R 
ACTTCTGCTC&GGTGGAATTGAACAAGAAGCGGGAGGC  TGAGTTTCAGAAACTGCGCAGG 
910  920  830  940  950  960 
D  L  £  £  A  T  L  O  H  £  &  M  V  A  A  L  R  K  iT  H 
GACCTGGAGGAGGCCACCCT  GCAGCATGAAGCTATGGTGGCTGCTCTTCGGAAGAAGC  AC 
9";0  980  990  1000  1010  1020 
A  0  S  H  &  £  L  G  E  0  1  D  N  L  0  R  V  K  0 
GCAGACAGT&TGGCTGAGC  T  TGGGGAGC  AGATTGACA~q  CTTGCAGCGGGTCAAACAG  AAG 
1030  1040  1050  1060  1070  1080 
L  £  K  E  K  S  £  L  K  M  E  T  0  0  L  S  S  N  A  E 
CTGGAGAAGGAGAAGAGTGAGCTGAAGATGGAGACT  GATGACCTCAGC  AGTAACGCAGAG 
1090  1100  1110  1120  1130  1140 
A  I  S  K  A  K  G  H  L  E  K  H  C  R  $  L  E  0  Q  V 
GCCATTTCCAAAGCCAAGGGCCACCTTGAAAAGATGTGCCGCTCTCTAGAAGATCAAG  TG 
1150  1160  1170  1180  1190  1200 
$  G  L  X  T  K  E  £  £  Q  g  t~  L  1  H  O  L  T  ~  Q 
AGTGGGCTTAAGACCAAGGAAGAGGAGCAGCAGCGGCT  GATCAATGACCTCACAGCACAG 
1210  1220  1230  1240  1250  1260 
R  /~  R  L  0  T  E  &  G  t  ¥  S  I~  O  L  D  E  0  0  A 
AGAGCGCGCCTGCAGACAGAAGCGGGTGAATATTCTCG&CAATTAGATGAGCAAGATGCT 
1270  !280  1290  1300  1310  1320 
L  V  S  0  L  S  R  S  K  Q  A  S  T  O  O  I  £  £  L  R 
TTAGTC  T  C  T  CAGCT  TT  C  AAG  GAGCAAGC  AAGCATCT  AC  TCAGCAGATT  GAAGAG  CT  GAAA 
2330  1340  1350  1360  1370  1380 
H  0  L  E  E  E  T  K  A  K  N  A  L  A  g  &  L  O  S  S 
CATCAACTAGAGGAAGAAACTAAAGCCAAGAACGCCCTGGCACACGCCCTGCAGTCCT  CC 
1390  1400  1410  1420  1430  1440 
R  H  O  C  D  L  L  R  r  0  Y  E  E  E  0  [  G  K  A  E 
CGCCATGACTGCGACCTGCTGCGGGAACAGTATGAGGAAGAGCAC~AAGGCAAAGCTG  AG 
1450  1460  1470  1480  1490  1500 
L  Q  R  A  L  S  K  A  N  S  £  V  &  O  11  R  T  K  ¥  £ 
CTGCAGAGGGCGCTGTCCAAGGCCAACAGTGAGGTT  GCCCAGTGGAGAACCAAATACGAG 
1510  1520  1530  1540  1550  1560 
T  D  A  I  Q  iT  T  E  £  L  E  E  &  K  K  iT  L  A  0  R 
ACGGAT  GCCATCCAGCGCACAGAGGAGCTGGAGGAGGCCAAGAAAAAGTTGGCCCAGCGC 
1570  1580  2580  1600  1610  1620 
L  0  E  k  £  £  H  v  £  &  V  N  A  K  C  A  5  L  £  K 
CTGCAAGAAGCTGAGGAACATGTAGAAGCTGTGAACGC  CA,AATGTGCTTCCC TT  GAGA.AG 
1630  1640  1650  1660  1670  1680 
7  K  0  R  ~  O  I~  £  v  £  0  L  H  L  D  V  £  R  S  H 
ACGAAGCAGCGGCTCCAGAATGAkGTTGAAGACCTCATGCTTGATGTGGAAAGGTCT~AT 
1690  1700  1710  1720  1730  1740 
AACAALDKKORNFDKVLSEW 
~AGCCTGTG~CCTTG&TAAG~GCAAAGG~CTTTGAC~TCCT&T~GAATGG 
1750  1760  1770  1780  1790  1800 
KOKY£ETQAELE&SOKESRS 
~AG~GT&T~AAACTCAG~TG~CTTGA~CCTCCCAGAAGGAGT~CGTT~ 
1810  1820  1830  1840  1050  1860 
LSTELrKVKNVYEESLDQLE 
CTTAGCACTGAGCTGTTC~TG~G~TGT~&T~TCCCTGGATCAACTCG~ 
1870  1080  1890  1800  1910  1820 
TLRRAHKHLOQ£ISDLTEQI 
AC~T~G~GCACAT~GAACTTGC~AGAT~CCTCACTG~GATT 
1930  1940  1950  1980  1970  1980 
AEGGKOIHELEKI~KOVE~£ 
GCAGAGGGAGGAAA~AAATTCATGAATTG~GAAAATAAAG~GTAG~CAAGAG 
1990  2000  2010  2020  2030  2040 
KCEIOAALEEAEASLEHEEG 
AAATGTGAAA~CT~TA~GG~AGAGGCATCTCTTG~CATG~GAAGGA 
2050  2060  2070  2080  2090  2100 
KI~RIOLE~NOVKS£VDRKI 
~GATTCTGCGTATCCAGCTTGAG~AAACCAAGTC~GTCTGAAGTTGATAGAAARATC 
2110  2120  2130  2140  2150  2160 
AEKDEEIOOLKRNHTRVV£T 
~AGAAAA~ATGAGGA/tqTTGAC~TG~GAAACCAC~ETAG&GTCGTGGA~CA 
2170  2100  2190  2200  2210  2220 
HOSTLDAEIRSRNDALRVKK 
AT~AGAGCACG~AT~AGAGATT&G~GCAGAAATGAT~TCTGAG~TCAAG~G 
2230  2240  2250  2260  2270  2250 
KMEGOLNEMEIQLHHANRLA 
AAAATGG~G~TCTG~TGAAAT~AAATCC~GAAC~TGCC~TCGCTTAG~ 
2290  2300  2310  2320  |320  3340 
AESLRNYRHTOGILKETQLH 
~AGAGTTT~GGAACTACAGG~CACCCAAGG~TCCTG~AAAC~AGCTCC&C 
2350  2360  2370  2380  2380  2400 
LOOALRGQ£DLKEQL&ZVER 
CT~ATGATGCT~CC~GGCCAGGA~ACCTCAAGGAACAGCT~C~TTGTGGAGC~ 
2410  2420  2430  2440  2450  2460 
RANLLQAEIEELHATLEQTE 
AGAGCC~CCTGCT~AGGCTG~ATCGAGGA~TGTGGGCC~TCTGGAACAGACAGAG 
2470  2480  2490  2500  2510  2520 
RSRKZAE~ELLO&SERVQLL 
AG~AGGAAAATCGCCG~CAG~TC~AT~CAGT~GTGTCCAGCTCCTC 
2530  2540  2550  2560  2570  2580 
HTQNTSLINTKKKLENDV$O 
CACACCCAG~TAC~GTCT~CACC~GAAGAAATTAGAJUqATG&CGTTTCCC~ 
2590  2600  2610  2620  2630  2640 
LOSEVEEVIOESRNAEEK&K 
CTCCAAAGTG~GT~GAAGT~TCC~G~TCACGC~T~G&GAAAGCC~G 
2650  2660  2670  2680  2690  2700 
KAITDAAMM&EELKKEODT$ 
~GGCCATCA~TG~T~TGGCT~AG~G~GAAGG~GGACACCA~ 
2710  2720  2730  2740  2750  2760 
AHLERMKKNLEQTVKDLOHR 
~CCACCT~A~GGATG~GAAG~CCTG~GCAGAC~TG~AC~AGCATC~ 
2770  2780  2790  2800  2810  2820 
LOEAEOLALKGGKKOIQKLE 
CTAGATGAGGCC~AGCTGGCGCTG~GGGTGGG~GAAGCAGATCCAGAAA~AG 
2830  2840  2850  2860  2870  2680 
ARVRELEG£VENEQKRN&£& 
~GGGTACGT~TTGAAGGAGA~TTGAAAATG~CAGAAACGT~TGCAGA~ 
2890  2900  2910  2920  2930  2940 
VKGLRKRDRRVKELT¥QTEE 
GTTAAAGGTTTACGGAAACATGACCGACG&GTAAAAG~CTCAC~ACC&~GAAG~ 
2950  2980  2970  2980  2990  3000 
DRKNVLRLQpLVDKL0&KVK 
GATC~G~TGTTCTCAG~TG~GGAC~TAGATAAATT~AGGCGAAGGTGAAA 
3010'  3020  3030  3040  3050  3060 
5YKROAEEA££QSNANLSKr 
TCATAC~GAGACAAGCTGA~AGGCTGAGGAAC~TCC~T~T~TCT&T~AAATTC 
3070  3080  3090  3100  3110  3120 
RKLQRELEEAEER&OZAESO 
CGCARACTCCAGCATGAGCT~GGCC~CG~CT~TT~TG~TCCCAG 
3130  3140  3150  3160  3170  3180 
VNKLRVKSREVRTKZS&E* 
GTC~¢AAATTGCG~TG~CGAGAGGTTCAC&CAAAAAT~GT~TAAAC& 
3190  3200  3210  3220  3230  3240 
CACCTGCCTGAT~TATC~GGCTG~GAAAG~ACAAAATGTGCT&T~TCAC 
3250  3280  3270  3280  3290  3300 
TT~TTTATGACGTTTATTTTC~GTTAAA~TG~TAAATAAAAACTAC~TAJU%TGT& 
3310  3320  3330  3340  3350  3360 
T&CATTP~%AAAAAA 
3370 B 
rY  t  l Tit t  rrt  v  IT  ,-- 
Probe 8  Probe A 
-  5~0  ,60  ,~,  20~0  .~0  do0  .t,0b, 
16gilt  eHincrl  APsII  aXMI 
Figure 1. A shows the DNA sequence and predicted encoded amino 
acids of the cDNA,  SMHCP.  The coding and 3' UTR nucleotide 
sequence and  derived amino  acid  sequence are  shown.  The ter- 
mination  codon  is  shown  as  *  B  shows  the  restriction  map  of 
pSMHCP.  Restriction  endonuclease  sites  are  indicated  for  the 
cloned  insert.  The  solid  bar  corresponds  to  protein  coding  se- 
quences. The solid line corresponds to the 3' UTR. Wavy lines cor- 
respond to vector sequence, Regions used to generate probes A and 
B  are indicated. 
per we report the isolation and characterization of a 3.4-kb 
cDNA clone, SMHCP, encoding the rod of a developmen- 
tally regulated human skeletal muscle myosin isoform. The 
complete nucleotide sequence of this cDNA has been deter- 
mined and compared to MHC sequences from several organ- 
isms.  Although all sarcomeric MHCs are highly homolo- 
gous, it appears that the final 20 amino acids encoded by 
MHC mRNAs, as well as the 3'  UTRs,  contain isoform- 
specific sequences which are maintained across divergent 
species. DNA sequence comparisons in these regions show 
that SMHCP is the human equivalent of a  previously de- 
scribed rat perinatal myosin isoform cDNA (20).  We show 
that the human perinatal MHC gene is expressed predomi- 
nantly in fetal skeletal muscle after 21 wk of gestation, and, 
in contrast to expression patterns seen in the rat, continues 
to be expressed in adult skeletal tissue. 
Materials and Methods 
Construction and Isolation of  Recombinant 
cDNA Clones 
A cDNA library was constructed in the ), gtl0 vector system following stan- 
dard procedures (12) using 5 #g poly (A)  ÷ mRNA isolated from 21-wk hu- 
man fetal heart tissue (provided by H. Blau, Stanford University School of 
Medicine). cDNA clones containing MHC  sequences were identified by 
plaque filter hybridization (5)  using a  nick translated (21) 2.0-kb human 
cDNA clone previously shown to encode an adult human/3/slow MHC iso- 
form (23). 
Restriction Endonuclease Mapping and DNA 
Sequence Analysis 
The eDNA insert was subcloned into the plasmid vector pTZ19R (Pharma- 
cia Fine Chemicals, Piscataway,  N J). Restriction endonuclease digestions 
were carried out following the conditions suggested by Maniatis (16). 
Nested deletions, for sequencing the insert of pSMHCP, were generated 
using the Erase-A-Base  system (Promega Biotec, Madison, WI) (6). Double- 
stranded plasmid DNA was sequenced using the Sequenase DNA sequenc- 
ing kit (U.S. Biochemical Corp., Cleveland, OH) following the method of 
Kraft et al.  (9).  Because of the overlapping nature of the deletions each 
nucleotide was sequenced an average of two times. 
Preparation of  Probes 
To generate the gene-specific radiolabeled RNA probe of pSMHCP, probe 
A (Fig. 1 B), a 194-bp Hinc II/Eco RI fragment (which includes 54 nucleo- 
tides encoding the final  18 amino acids and the entire 3' UTR) was sub- 
cloned into pGEM-1 (Promega Biotec). Following the manufacturer's sug- 
gested protocol,  1 ttg of linearized plasmid DNA was used to generate 
radiolabeled anti-sense cRNA  using uridine 5'-lc¢-32P] tripbosphate (10 
mCi/ml) (Amersham Corp., Arlington Heights, IL) and T7 RNA polymer- 
ase (Promega Biotec). When used in the RNase protection studies, the probe 
was further purified by digesting the DNA template with RNase-free DNase 
for 15 min at 37°C. 
Probe B (Fig.  1 B), a 481-bp fragment, was generated from an Eco RI/ 
Hinc II digest of pSMHCP and radioactively labeled with [ct)2p] dCTP 
using a random-primer oligolabeling kit (Pharmacia Fine Chemicals). 
The /~/slow MHC  specific probe was generated from a  subclone of a 
cDNA previously characterized (23). A 238-bp fragment, containing 54 bp 
encoding the final  18 amino acids of the MHC, 117 bp of its 3' UTR, a poly 
(A) tail of 20 nucleotides, and 47 bp derived from Okayama-Berg plasmid 
was subcloned into pGEM-1. Linearized DNA from this subclone was used 
to generate an anti-sense radiolabeled cRNA in a manner identical to that 
described above for probe A. 
RNA Isolation 
Total cellular RNA was isolated from autopsy samples of fetal and adult 
cardiac and skeletal  tissues (gifts from Dr. S. Kohtz, Mt. Sinai College of 
Medicine and from Dr. M. Thompson, University of Pittsburgh, School of 
Medicine) using a guanidine isothiocyanate extraction, cesium chloride pel- 
leting protocol (16). 
Genomic DNA Analysis and Hybridization Conditions 
Human genomic DNA was digested with restriction endonucleases, and 30 
~tg per lane was electrophoresed in 1% agarose-TAE (40 mM Tris-acetate, 
2 mM EDTA) gels. DNA was transferred to filters according to Southern 
(26) except that GeneScreen (New England Nuclear, Boston, MA) was used 
in place of nitrocellulose. The DNA was fixed to the filters by a 5-min ex- 
posure to shortwave UV light followed by baking for 1 h at 80°C. 
For random-primed probe hybridizations, the filters were prehybridized 
for at least 2 h in 5x  SSC (20x  is 3 M NaC1,  300 mM sodium citrate), 
!×  Denhardt's solution, 50 mM NaH2PO4-H20 and 150 ttg/ml heat dena- 
tured salmon sperm DNA. Filters were hybridized overnight at 65°C in the 
same solution with the addition of dextran sulfate to a final concentration 
of 10%,  and 2  ×  105 cpm/ml radiolabeled probe. After hybridization, 
filters were washed in 2×  SSC, 0.2% SDS for 1 h at the hybridization tem- 
perature. 
For hybridizations with labeled cRNA probes, filters were prehybridized 
for at least 2 h in 50% formamide, 5× SSPE (20× is 3.6 M NaCI, 200 mM 
NaH2POa.H20,  20  mM  EDTA,  pH  7.4),  2x  Denhardt's solution,  and 
0.2% SDS. Filters were hybridized overnight at 60°C in the same solution 
with the addition of I  ×  106 cpm/ml of 32P-radiolabeled  cRNA.  Filters 
were washed in I x  SSPE for 1 h at 65°C. All filters were exposed to X-Omat 
AR film (Eastman Kodak Co., Rochester, NY) with intensifying screens 
(Cronex, DuPont Co., Wilmington, DE) at  -70°C. 
RNase Protection Studies 
RNase protection studies were carried out following the protocol of Melton 
et al.  (17). 30 #g total  RNA were used for each hybridization.  1  x  106 
cpm/ml of probe A or the B/slow MHC probe was ethanol precipitated with 
the various RNAs, resuspended in 10 #1 of 80%  formamide hybridization 
buffer,  and placed at 60°C for 3 h. Hybridization was followed by RNase 
treatment for 30 min at 30°C using 96/.,g/ml Ribonuclease A and 19 U/ml 
Ribonuclease T1. RNase-resistant products were run on 8 M urea, 6% bis- 
acrylamide sequencing gels. 
Results 
Isolation and DNA Sequence Analysis of  a Perinatal 
MHC cDNA Clone 
To  isolate  and  characterize  cDNAs  representing  develop- 
mentally  regulated human MHC  genes,  we  constructed a 
eDNA  library from fetal cardiac tissue.  Due to the highly 
conserved nature of sarcomeric  MHCs,  it was possible to 
isolate MHC eDNA clones from this library using a previ- 
ously  isolated  sarcomeric  MHC  eDNA  as  a  probe.  The 
eDNA used here as a probe encodes the light meromyosin 
region of an adult/3 cardiac/slow skeletal MHC and cross- 
hybridizes to multiple MHC genes (22). We screened 4  x 
Feghali  and Leinwand Perinatal Myosin Heavy Chain  1793 10  ~ clones from the fetal cardiac eDNA library, and selected 
a 3.4-kb cDNA, SMHCP, for further study due to its unique 
restriction pattern when compared to those of  previously iso- 
lated MHC cDNAs. 
The entire cloned insert of SMHCP was subjected to DNA 
sequence analysis through the generation of nested deletions. 
The nucleotide sequence,  and  its  derived amino  acid  se- 
quence are shown in Fig. 1 A. When compared with an entire 
sarcomeric MHC sequence (27), SMHCP was determined to 
extend from codon 812 through codon 1,894 (out of 1,894), 
and to include the complete 3' UTR of the MHC mRNA and 
the poly (A) tail.  SMHCP therefore encodes a polypeptide 
which would form the rod portion of the molecule, ending 
18 amino acids before the beginning of the globular subfrag- 
ment one head region. A partial restriction map of SMHCP 
is shown in Fig.  1 B. 
To examine the level of homology between SMHCP and 
other  MHCs,  its  sequence  was  compared  with  all  mam- 
malian DNA sequences available in published reports. This 
analysis revealed that SMHCP is most homologous to the 
cDNA encoding a perinatal isoform of myosin identified in 
rat hind-leg muscle (20).  Table I  shows a comparison be- 
tween the final 257 amino acids (the length of the previously 
described rat perinatal eDNA) encoded by SMHCP, and the 
equivalent region of five rat and three human striated muscle 
MHC cDNAs. It is apparent from this comparison that the 
amino acids encoded by SMHCP are most homologous to 
the rat perinatal MHC isoform with differences in only 12 
of the 257 compared amino acids (4.7 %), eight of which are 
conservative. Comparison of the amino acids encoded by 
SMHCP with the human adult fast MHC isoform, shows 23 
differences out of 258 amino acids (8.9%); almost twice as 
many changes as when the comparison is made to the rat 
perinatal MHC sequence. The perinatal MHC isoform ap- 
pears to be least similar to embryonic MHC isoforms; more 
than 18% of the amino acids are different in both the rat and 
human isoforms. 
The identification of SMHCP as encoding a human perina- 
tai MHC isoform is even more apparent when 3' UTR se- 
quences are compared. When the 3' UTRs of MHC cDNAs 
from human and rat are compared, a high degree of homol- 
ogy is maintained only between sequences of analogous iso- 
forms (23). Table I shows that, in this region, the nucleotide 
differences between the human clone, SMHCP, and the rat 
perinatal isoform cDNA are the lowest (38.5%). The other 
comparisons show that the 3' UTR of SMHCP is also similar 
to the rat fast skeletal lib isoform cDNA, varying at 44.1% 
of the nucleotides. Comparisons of SMHCP to slow MHC 
isoform cDNAs show differences as high as 74.2%. 
An interesting feature of MHC isoform sequence is seen 
when the carboxyl-terminal 20 amino acids encoded by four 
human MHC cDNAs and their rat equivalents are examined 
(Table II). Using the final 20 amino acids of SMHCP as the 
standard sequence, differences in this region among the other 
isoforms are indicated. It is evident that the amino acids en- 
coded by SMHCP are most similar to the rat perinatal iso- 
form, showing 100% homology in this region. The other hu- 
man  and  rat  sequences  show  similar  conservation  when 
homologous isoforms are examined. It appears that this re- 
gion of the myosin molecule is isoform specific, and is main- 
tained across species, suggesting that it may have a functional 
role. 
The gene-specificity of this region of SMHCP is demon- 
strated when a radiolabeled probe, probe A (shown in Fig. 
1 B),  generated from the sequences encoding the final  18 
amino acids of SMHCP, as well as its entire untranslated re- 
gion (140 bp), is hybridized to a blot of total human genomic 
DNA (Fig. 2 A). This probe binds to a single band in Eco 
RI, Hind III, and Pst I digests of human genomic DNA. A 
500-bp radiolabeled fragment, probe B (Fig. 1 B), from the 
Table L  Comparison  of the Human Perinatal 
MHC cDNA and Amino Acid Sequences  to Human and 
Rat Skeletal  and Cardiac  MHCs 
Difference in  Difference in  Difference 
coding region  coding region  in 3' UTR 





Fast skeletal Ila 






101/771  (13.1%)  12/257  (4.7%)  38.5 
165/786 (21.0%)  51/262  (19.5%)  56.8 
61.7 
44.1 
203/774 (26.2%)  50/258 (19.3%)  74.2 
191/786  (24.3%)  49/262  (18.7%)  58.1 
107/774  (13.8%)  23/258  (8.9%)  58.2 
197/774  (25.4%)  46/258  (17.8%)  73.4 
The nucleotide and derived amino acid sequences encoded by the final 771 bp 
of SMHCP and its 3' UTR, were compared with analogous regions from seven 
other MHC cDNAs. These include the rat: perinatal (pFOD5) (20), embryonic 
(pMHC25)  (27),  adult  fast oxidative  IIa (pMHC40),  and  fast glycolytic  lib 
(pMHC62) (3' UTR only) (19), and l~/slow skeletal (pCMHC5) (15) isoforms; 
and the human:  embryonic  (pSMHCE)  (Karsch-Mizrachi,  I., M.  Travis,  H. 
Blau, and L. Leinwand, manuscript submitted for publication), adult fast skele- 
tal (pSMHCA)  (23), and/~/slow skeletal (pSMHCZ)  (23) isoforms. 
Table 11.  Comparison  between the Final 20 Amino Acids 
of SMHCP and Homologous Regions from Five Rat 
MHC Sequences  and Their Human Equivalents 











Rat slow skeletal 
SQVNKLRVKSREVHTKI  SAE. 
******** *  ********* *  ~. 
** * * *  * *A * T*DFTS  SRMVHESEE- 
** * * * * *A * T*DFT  S S RMVHESEE. 
********************** 
********  *  *******VI  SEE- 
*******A***DIG**GLNEE- 
*******A*  **DIGA*GLNEE- 
The derived amino acid sequence of the human perinatal cDNA, SMHCP, en- 
coding the final 20 carboxy terminal residues, was compared to an equivalent 
region  from  seven other  MHC  cDNA  clones.  The amino  acid sequence of 
SMHCP is printed in full across the first line of sequence. Differences between 
SMHCP and the other sequences are highlighted at the appropriate  residues, 
identical residues are denoted by *. There are no differences in this region be- 
tween  SMHCP and  sequences from the  rat perinatal  MHC  isoform pFOD5 
(20).  Other sequences include rat:  embryonic (pMHC25)  (27),  adult fast lla 
and lib skeletal (pMHC40/pMHC62)  (19),  B/slow skeletal (pCMHCS) (15); 
and human: embryonic (pSMHCE) (Karsch-Mizrachi,  1., M. Travis,  H. Blau, 
and L.  Leinwand,  manuscript  submitted for publication),  adult  fast skeletal 
(pSMHCA) (23), and/~/slow  skeletal (pSMHCZ)  (23) cDNAs.  The termina- 
tion codon is shown as .. 
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RNA,  and does not react with RNA isolated from fetal or 
adult cardiac tissue, or from rat liver RNA (data not shown). 
To more precisely define and quantitate the expression of 
this gene in fetal and adult skeletal tissue, RNA was exam- 
ined using  more  sensitive ribonuclease protection assays. 
Anti-sense  radiolabeled RNA  transcribed  from the gene- 
specific subclone of pSMHCP, probe A, was hybridized to 
fetal and adult skeletal, fetal cardiac, and adult liver RNAs. 
Fig. 3 shows protection of a full length 194-bp band in 21-wk 
fetal skeletal tissue, but not in cardiac tissue from the same 
period.  Full-length  protection in  two adult  skeletal  RNA 
samples was also seen, but at significantly lower levels than 
in fetal skeletal tissue. For example, lane 2 is a  1-h exposure 
of the protected product from fetal skeletal tissue. However, 
a  63-h exposure (lane 4)  for the first adult sample, and a 
336-h exposure (lane 5) for the second are required to obtain 
signals of similar intensity. The adult skeletal muscle was ob- 
tained from two individuals,  ages 78 and 57,  respectively. 
The additional  lower molecular weight bands  seen in  the 
skeletal  lanes  are  most  likely the  result  of the  somewhat 
degraded nature of the RNA used in these studies. The bands 
which are the result of  probe background can be seen in lanes 
7 and 8 of Fig. 3, which show the result of RNase incubation 
with the radiolabeled probe hybridized in the presence of 
liver and yeast tRNA alone. Despite the isolation of SMHCP 
from a  fetal cardiac library,  we were unable to detect the 
presence of the perinatal myosin isoform in fetal cardiac tis- 
sue by RNase protection (lane 6, Fig.  3) or Northern blot 
analysis (data not shown). The presence of MHC sequences 
in this RNA sample is confirmed by the protection of a full- 
length/3 cardiac/slow skeletal MHC probe shown in lane//. 
These results lead us to conclude that the fetal cardiac tissue 
used to make the original eDNA library was expressing a 
myosin isoform not usually found in this tissue. In summary, 
the human perinatal MHC isoform is expressed in 21-wk fetal 
skeletal tissue at very high levels, and its expression is down- 
regulated in adult skeletal tissue. 
Figure 2. Hybridization analysis of human genomic DNA with two 
probes derived from pSMHCP. Total genomic DNA was digested 
with endonucleases Eco RI (lane 1 ), Hind III (lane 2), or Pst I (lane 
3), electrophoresed, and transferred to GeneScreen. In A, the filter 
was hybridized to radiolabeled probe A, indicated in Fig.  1 B. In 
B, the filter was hybridized to radiolabeled probe B, indicated in 
Fig.  1 B. The size markers (in kilobases) are from X phage DNA 
digested with Hind III. 
5' end of SMHCP, encoding sequences from the subfragment 
2  region, hybridizes to numerous bands (Fig.  2 B). 
Analysis of  Expression  of the Human Perinatal 
MHC Gene 
The pattern of expression of the gene encoding SMHCP was 
determined through hybridization of the isoform-specific ra- 
diolabeled RNA probe, probe A, to RNA samples isolated 
from adult and fetal skeletal and cardiac tissue. RNA hybrid- 
izations,  under  conditions  where  100  pg  of homologous 
RNA can be detected, show that the probe hybridizes strong- 
Discussion 
The results shown here demonstrate that SMHCP encodes a 
developmentally regulated human  MHC  isoform,  the pri- 
mary site of expression of which is mid-gestation fetal skele- 
tal muscle. DNA sequence analysis indicates that SMHCP 
is the human equivalent of a previously described rat perina- 
tal MHC isoform which is present in rat skeletal tissue at 
3 wk of gestation, reaching maximum levels of expression 
at 7 d postbirth, and which is not expressed in the hind-leg 
tissue of the adult rat (20). By RNA analysis, we have found 
that SMHCP is not expressed in fetal tissue before 13 wk of 
gestation (data not shown). RNase protection studies demon- 
strated that SMHCP is expressed in 21-wk human fetal skele- 
tal and human adult skeletal tissue, but is not expressed in 
21-wk fetal cardiac tissue.  In contrast to our results,  Peri- 
asamy et al. (20) did not see expression of the rat perinatal 
isoform in adult skeletal tissue, although the perinatal iso- 
form mRNA has been seen in adult masseter muscle at low 
levels using S1  nuclease analysis (7). The difference in the 
pattern of expression between the rat and human isoforms in 
adult skeletal tissue may be due to species differences in the 
Feghali  and Leinwand Perinatal  Myosin Heavy Chain  1795 Figure  3.  Expression  of  SMHCP 
mRNAs in fetal and adult skeletal tis- 
sue  by  RNase  protection  studies. 
Adult skeletal and fetal cardiac and 
skeletal RNA samples as well as con- 
trois  were hybridized  with  radiola- 
beled  anti-sense  cRNA  generated 
from the  isoform-specific  subclone 
of pSMHCP, probe A, and an iso- 
form-specific subclone ofpSMHCZ, 
the  /~/slow MHC cDNA  (23).  Af- 
ter hybridization,  the samples were 
digested  with  ribonucleases  A  and 
TI, then run on a denaturing gel to 
identify  all  RNase-resistant  frag- 
ments. Lane m shows a Hae III  digest 
of  ~X174 DNA  radiolabeled  with 
[,y_32p] ATP. The sizes of the bands 
generated, in base pairs, are listed on 
the left side of the figure. Lane 1 is 
the  radiolabeled  cRNA  generated 
from probe A,  which  was  not  di- 
gested with RNases.  Lanes 2 and 3 
are 1-h exposures of the bands gen- 
erated using total RNA from a 21-wk 
fetal skeletal sample and from a 57-yr-old adult skeletal sample,  respectively.  Lane 4 is a 63-h exposure of a 78-yr-old adult skeletal 
sample hybridized to probe A. Lane 5 is a 336-h exposure  of the same skeletal sample seen in lane 3 as a  l-h exposure.  Lane 6 was 
generated using a 21-wk fetal cardiac RNA sample. Lane 7 was generated using adult rat liver total RNA. The RNase-resistant bands 
resulting from the RNase treatment of the probe alone are seen in lane 8. Lane 9 is the radiolabeled cRNA probe from the ~//slow sequence 
(pSMHCZ) which was not digested with RNase. Lane 10 is the/~/slow probe incubated with liver RNA. Lane//is the expected full-length 
protected fragment obtained when the/~/slow probe is hybridized with the 21-wk fetal cardiac RNA sample. The cRNA generated from 
probe A is 208 bp long (194 bp from pSMHCP and 14 bp from the pTZI9R vector). Full-length protection of a 194-bp fragment is seen 
only in lanes 2, 4, and 5. 
mechanisms which control the developmental regulation of 
the expression of the isoform. 
The presence of SMHCP in the fetal cardiac cDNA library 
from which it was isolated appears to have been due to an 
atypical expression of this isoform in the cardiac tissue used 
to make the library. The fetal cardiac RNA used to make the 
cDNA library was not available for further analysis. There- 
fore, to examine further the  MHC composition of this  li- 
brary, we screened the fetal cardiac library with other MHC- 
specific probes. From this analysis, only two types of MHC 
were found in the library: cDNAs corresponding to the iso- 
form  encoded  by  SMHCP,  and  cDNAs  encoding  the  ct 
cardiac MHC isoform, a  MHC gene expression is cardiac- 
specific (13).  Therefore, the contents of the cDNA library 
represent  cardiac  tissue  expression.  In  addition,  no  fetal 
skeletal MHC clones were detected. We were unable, how- 
ever, to detect B cardiac MHC cDNAs, which are normally 
present at this stage of cardiac development. This suggests 
that the distribution of MHC cDNA clones in this library is 
not representative of MHC mRNA distribution  in normal, 
healthy fetal cardiac muscle. 
Tsuchimochi et al. (28) have shown, through antibody re- 
activity and peptide mapping, that an MHC isoform distinct 
from the previously identified cardiac a  and/~ isoforms is 
abundantly expressed in fetal ventricular myofibers. The per- 
centage of fibers expressing this isoform decreases signifi- 
cantly after birth, and is up-regulated in patients with dilated 
cardiomyopathies. Expression of this isoform in fetal or adult 
skeletal tissue was not addressed.  It seems unlikely that we 
have isolated the cDNA corresponding to the isoform they 
have identified since we have not been able to reproducibly 
detect expression of this gene in fetal cardiac muscle, but it 
does suggest the presence of more than two MHC isoforms 
in cardiac tissue, and the ability of an isoform to be abnor- 
mally expressed in a  tissue under pathological conditions. 
The  maintenance,  through  evolution,  of an  MHC  gene 
family capable of undergoing  tissue-specific and develop- 
mentally regulated expression, suggests a physiologic func- 
tion for the many isoforms. Regions of amino acid identity 
in the myosin molecule, maintained among the isoforms and 
across species most likely encode properties intrinsic to the 
myosin molecule such as heavy chain association, ATP bind- 
ing, and filament formation (see reference 29). In contrast, 
isoform-specific sequences may encode regions which con- 
fer functional diversity (2).  For example, the isoform-spe- 
cific sequences found at the extreme 3' ends of the myosin 
rods may play a role in regulating the association of homolo- 
gous heavy chains. A complete understanding of the physio- 
logical role of the various MHC isoforms will most likely 
come only after a detailed evaluation of MHC sequences and 
their relation to the functional properties of the molecules. 
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